Presentation THT 2025 Mitigating Post-Operative Right Ventricular Dysfunction After Left Ventricular Assist Device: The RV Protection Study Presenter: Anthony Kanelidis February 13, 2025
Presentation THT 2025 Sodium Glucose CoTransporter-2 Inhibitor Following Left Ventricular Assist Device Implantation: A Randomized Controlled Trial Presenter: Mary Acosta February 12, 2025
Presentation THT 2025 Barostim With Durable Left Ventricular Assist Device (LVAD) Therapy Presenter: Kanika Mody February 12, 2025
Presentation THT 2025 The Use of Cardiac Contractility Modulation(CCM) and Durable Left Ventricular Assist Device (LVAD) for Patients With Class IV CHF Presenter: Kanika Mody February 12, 2025
Presentation THT 2025 Normalized Hemodynamics and Unique Pressure/Flow Relationships at Submaximal Exercise in Left Ventricular Assist Device-Supported Patients Presenter: Van-Khue Ton February 12, 2025
Presentation THT Abstracts 2025 Use of Vericiguat in Durable Left Ventricular Assist Device Patients February 11, 2025
Presentation THT Abstracts 2025 Barostim With Durable Left Ventricular Assist Device (LVAD) Therapy Presenter: Kanika Mody February 11, 2025
Presentation THT Abstracts 2025 The Use of Cardiac Contractility Modulation(CCM) and Durable Left Ventricular Assist Device (LVAD) for Patients With Class IV CHF Presenter: Kanika Mody February 11, 2025
Presentation THT Abstracts 2025 Efficacy of Silverlon Silver Plated Dressing Pad in Reducing Left Ventricular Assist Device Driveline Infections When Compared to Chlorhexidine Impregnated Disc Presenter: John DePietro February 11, 2025
Presentation THT Abstracts 2025 Normalized Hemodynamics and Unique Pressure/Flow Relationships at Submaximal Exercise in Left Ventricular Assist Device-Supported Patients Presenter: Van-Khue Ton February 11, 2025
Presentation THT 2025 Use of Vericiguat in Durable Left Ventricular Assist Device Patients Presenter: Boaz Elad February 11, 2025
Presentation THT 2025 Efficacy of Silverlon Silver Plated Dressing Pad in Reducing Left Ventricular Assist Device Driveline Infections When Compared to Chlorhexidine Impregnated Disc Presenter: John DePietro February 11, 2025
Presentation THT Abstracts 2024 Durable Left Ventricular Assist Devices Improve Microcirculatory Health Presenter: Boaz Elad March 05, 2024
Presentation THT Abstracts 2024 Glucagon-Like Peptide-1 Agonist Experience in Patients With Left Ventricular Assist Devices Presenter: Boaz Elad March 05, 2024
Presentation THT Abstracts 2024 Center variability in patient management may influence incidence of infection during durable left ventricular assist device support 2013 an analysis from the ASPIRE Survey and STS Intermacs Presenter: Jennifer Cowger March 05, 2024
Presentation THT Abstracts 2024 Functional Outcomes Following Temporary Mechanical Circulatory Support Bridging to Left Ventricular Assist Device (LVAD) Presenter: John Eisenga March 05, 2024
Presentation THT 2024 Direct Oral Anti-Coagulant Apixaban in Left Ventricular Assist Devices (DOAC LVAD) Study Presenter: Palak Shah March 05, 2024
Presentation THT Abstracts 2024 The Impact of Preoperative Impella Support on Left Ventricular Assist Device Survival and Quality of Life Presenter: Timothy George March 04, 2024
Presentation TCT 2023 TCT 741: Clinical Outcomes of Ischemic Cardiomyopathy vs. Non-Ischemic Cardiomyopathy in Women with Left Ventricular Assist Device Presenter: Priyadarshini Dixit October 25, 2023
Presentation TCT 2023 TCT 879: Novel Percutaneous Ventricular Assist Device-Assisted Left Main PCI in a Patient With Severely Reduced Left Ventricular Ejection Fraction Presenter: Jurij Avramovic October 24, 2023